Journal of Pain Research
Volume 10, 2017 - Issue
Open access
207
Views
108
CrossRef citations to date
0
Altmetric
Original Research
A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty
Neil Singla1 Lotus Clinical Research, Pasadena, CACorrespondence[email protected]
, Harold S Minkowitz2 Memorial Hermann Memorial City Medical Center, Houston, TX
, David G Soergel3 Trevena, Inc, King of Prussia, PA, USA
, David A Burt3 Trevena, Inc, King of Prussia, PA, USA
, Ruth Ann Subach3 Trevena, Inc, King of Prussia, PA, USA
, Monica Y Salamea3 Trevena, Inc, King of Prussia, PA, USA
, Michael J Fossler3 Trevena, Inc, King of Prussia, PA, USA
& Franck Skobieranda3 Trevena, Inc, King of Prussia, PA, USA
show all
Pages 2413-2424
|
Published online: 06 Oct 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.